WO2008020329A3 - Administration of cells and cellular extracts for rejuvenation - Google Patents

Administration of cells and cellular extracts for rejuvenation Download PDF

Info

Publication number
WO2008020329A3
WO2008020329A3 PCT/IB2007/003266 IB2007003266W WO2008020329A3 WO 2008020329 A3 WO2008020329 A3 WO 2008020329A3 IB 2007003266 W IB2007003266 W IB 2007003266W WO 2008020329 A3 WO2008020329 A3 WO 2008020329A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
relates
compositions
tissues
skin
Prior art date
Application number
PCT/IB2007/003266
Other languages
French (fr)
Other versions
WO2008020329A2 (en
Inventor
Runhild Gammelsaeter
Jan Remmereit
Original Assignee
Regenics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenics As filed Critical Regenics As
Priority to EP12178381.5A priority Critical patent/EP2656832B1/en
Priority to EP07825530.4A priority patent/EP2101724B1/en
Priority to CA2651856A priority patent/CA2651856C/en
Priority to JP2009508547A priority patent/JP5641734B2/en
Priority to AU2007285483A priority patent/AU2007285483B2/en
Publication of WO2008020329A2 publication Critical patent/WO2008020329A2/en
Publication of WO2008020329A3 publication Critical patent/WO2008020329A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982—Reproductive organs; Embryos, Eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Abstract

The invention describes methods and agents for improving cosmetic appearance, for promoting, improving or restoring health of cells and tissues, preferably skin, and more preferably, for restoring aged or damaged skin to a healthy appearance. This invention relates to the use of cells and cellular extracts in rejuvenation and healing technologies thereby improving healing and regeneration of all bodily tissues and organs. The present invention relates to compositions and methods of managing, preventing, and treating scars. The invention also relates to prevention of deterioration, damage and malfunction of cells and tissues, and to promote, improve or exceed cellular function in order to promote, improve and exceed appearance, vitality and health. In some embodiments, the invention relates to compositions of cells, eggs, cell extracts, egg extracts, and extract components such as purified nucleic acids, polypeptides, lipids, carbohydrates or other natural products. Said components can also be synthesized. In other embodiments, the cells are differentiable cells preferably stem cells or eggs. In some embodiments, compositions are used in a method that comprises application of compositions to tissues, including skin and/or wounds after removal of tissue surface layers. In other embodiments, the invention relates to methods of dedifferentiation of cells and/or dedifferentiation followed by differentiation. In other embodiments, the invention relates to managing, preventing, and treating skin diseases.
PCT/IB2007/003266 2006-05-11 2007-05-11 Administration of cells and cellular extracts for rejuvenation WO2008020329A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP12178381.5A EP2656832B1 (en) 2006-05-11 2007-05-11 Compositions for use in wound healing
EP07825530.4A EP2101724B1 (en) 2006-05-11 2007-05-11 Administration of cellular extracts for rejuvenation
CA2651856A CA2651856C (en) 2006-05-11 2007-05-11 Administration of cells and cellular extracts for rejuvenation
JP2009508547A JP5641734B2 (en) 2006-05-11 2007-05-11 Administration of rejuvenating cells and cell extracts
AU2007285483A AU2007285483B2 (en) 2006-05-11 2007-05-11 Administration of cells and cellular extracts for rejuvenation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79956006P 2006-05-11 2006-05-11
US60/799,560 2006-05-11

Publications (2)

Publication Number Publication Date
WO2008020329A2 WO2008020329A2 (en) 2008-02-21
WO2008020329A3 true WO2008020329A3 (en) 2009-10-22

Family

ID=39082410

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/003266 WO2008020329A2 (en) 2006-05-11 2007-05-11 Administration of cells and cellular extracts for rejuvenation

Country Status (8)

Country Link
US (4) US8075920B2 (en)
EP (2) EP2656832B1 (en)
JP (2) JP5641734B2 (en)
AU (1) AU2007285483B2 (en)
CA (1) CA2651856C (en)
DK (1) DK2656832T3 (en)
RU (2) RU2421208C2 (en)
WO (1) WO2008020329A2 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007285483B2 (en) 2006-05-11 2011-12-22 Regenics As Administration of cells and cellular extracts for rejuvenation
KR20090023631A (en) * 2006-06-26 2009-03-05 노파르티스 아게 Organic compounds
PL2192907T3 (en) * 2007-08-16 2018-10-31 Remedor Biomed Ltd. Erythropoietin and fibronectin compositions for therapeutic applications
IL189569A0 (en) * 2008-02-18 2009-02-11 Mina Faran Dr Cosmetic and dermatological composition for psoriatic skin treatment
WO2009128570A1 (en) * 2008-04-14 2009-10-22 Seung Yoon Lee Treating erythematotelangiectatic rosacea or papulopustular rosacea with narrow-band infrared light radiation and radiation kits therefor
WO2009127249A1 (en) * 2008-04-16 2009-10-22 United Technologies Ut Ag Method for identifying compounds suitable for stimulation of stem cell production in skin
AU2013273788B2 (en) * 2008-05-09 2016-06-16 Regenics As Cellular extracts
EP2296676B1 (en) 2008-05-09 2016-11-02 Regenics AS Cellular extracts
EP2533859B1 (en) 2010-02-10 2016-04-06 Nayacure Therapeutics Ltd Pharmaceutical compositions for the treatment and prevention of cancer
WO2011109512A1 (en) * 2010-03-02 2011-09-09 Vindico Nanobio Technology, Inc. Compositions and methods for treating or preventing immuno-inflammatory disease
AU2011249478B2 (en) * 2010-05-06 2014-12-04 Regenics As Use of cellular extracts for skin rejuvenation
AU2015201116B2 (en) * 2010-05-06 2016-12-08 Regenics As Use of cellular extracts for skin rejuvenation
US8192429B2 (en) 2010-06-29 2012-06-05 Theravant, Inc. Abnormality eradication through resonance
US20120114776A1 (en) * 2010-11-04 2012-05-10 Janos Feher Methods for preparing probiotic nanoparticles
EP2799079A1 (en) * 2010-11-12 2014-11-05 Allergan, Inc. Metabolized conditioned growth medium and methods of use
CN103841956B (en) * 2011-03-27 2016-11-09 奥麒化工有限公司 Regulation epigenetic DNA methylation is to cause cell to take the DNA methylation pattern relevant to young cell
US10660987B2 (en) * 2011-04-29 2020-05-26 Converge Biotech Inc. Conformal coating of cells for immunoisolation
GB201110783D0 (en) * 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
EP2726603B1 (en) 2011-06-29 2020-04-01 Biorestorative Therapies, Inc. Brown fat cell compositions and methods
US20130052244A1 (en) * 2011-08-30 2013-02-28 Mark Weinreb Stem Cell Compositions and Methods
US9458131B2 (en) * 2011-11-08 2016-10-04 Emory University Compounds and compositions used to epigenetically transform cells and methods related thereto
PE20150269A1 (en) 2012-01-23 2015-02-19 Restorsea Llc COSMETIC COMPOSITION CONTAINING AN EGG Hatching PROTEIN
WO2014035306A1 (en) * 2012-08-31 2014-03-06 Sca Hygiene Products Ab Hygiene article with odour control substance and method for producing it
KR102398811B1 (en) 2012-12-10 2022-05-16 앨러간 파마슈티컬스 인터내셔널 리미티드 Scalable three-dimensional elastic construct manufacturing
EP3459522B1 (en) * 2012-12-10 2021-02-17 Regenics AS Use of egg cellular extracts for wound treatment
KR102134938B1 (en) * 2012-12-21 2020-07-17 아쿠아 바이오 테크놀로지 에이에스에이 Cosmetic composition from fish hatching fluid
NL2010225C2 (en) * 2013-02-01 2014-08-04 Conradus Ghosal Gho Composition and method for preserving, transporting and storing living biological materials.
RU2539750C2 (en) * 2013-04-09 2015-01-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Method of evaluating immunosuppressive properties of human mesenchymal stromal cells
FR3004353B1 (en) * 2013-04-10 2015-05-15 Fabre Pierre Dermo Cosmetique SYNERGISTIC ASSOCIATION OF ALANINE-GLUTAMINE, HYALURONIC ACID AND OAT EXTRACT, AND USE THEREOF IN A COMPOSITION FOR SCALING AND REPAIRING SKIN LESIONS
AU2014306362B2 (en) 2013-08-13 2019-04-18 Allergan Pharmaceuticals International Limited Regeneration of damaged tissue
RU2567004C2 (en) * 2013-11-14 2015-10-27 Общество с ограниченной ответственностью "Экселлент Кволити Брендинг" Method of separating fibroblasts, method of creating thereof-based biotransplant (versions) and method of regenerating human tissues (versions)
CA2933367A1 (en) 2013-12-13 2015-06-18 Restorsea, Llc Exfoliative hair retention-promoting formulation
US9592193B2 (en) * 2014-05-15 2017-03-14 Pet Research Labs, Llc Canine sebum substitute
AU2015259509A1 (en) 2014-05-16 2016-11-24 Restorsea, Llc Biphasic cosmetic
RU2565548C1 (en) * 2014-08-05 2015-10-20 Дмитрий Андреевич Журавлёв Method of producing of pluripotent stem cells
JP6528228B2 (en) * 2014-10-21 2019-06-12 ポーラ化成工業株式会社 Evaluation method of skin firmness
US10420802B2 (en) * 2015-12-10 2019-09-24 Aesthetics Biomedical, Inc. Topical formulation for skin care
CN109788736B (en) * 2016-08-09 2022-05-27 先正达参股股份有限公司 Insecticidal proteins
CH713169B1 (en) 2017-05-22 2018-05-31 La Prairie Group Ag Cosmetic or dermatological preparation containing a fish extract.
CH713170B1 (en) 2017-05-22 2018-05-31 La Prairie Group Ag Cosmetic or dermatological preparation containing an aqueous and a lipophilic fish extract.
RU2699061C1 (en) * 2018-05-30 2019-09-03 Государственное бюджетное учреждение здравоохранения г. Москвы "Московский научно-практический центр дерматовенерологии и косметологии Департамента здравоохранения г. Москвы" Method of treating exchorinated acne
WO2020079484A1 (en) * 2018-10-19 2020-04-23 Regenics As Use of egg cellular extract for wound healing
WO2020101620A2 (en) * 2018-11-14 2020-05-22 Bayrak Habib Hair growing and/or strengthening product
WO2020180311A1 (en) * 2019-03-06 2020-09-10 Zen-Bio, Inc. Plant-based exosome compositions and use thereof for rejuvenating skin
CN109991201A (en) * 2019-04-11 2019-07-09 大连理工大学 A method of the gold nanoclusters being located in the surface ZIF-8 are used to improve the specific selectivity of its fluorescence intensity and detection
WO2021022181A1 (en) * 2019-07-31 2021-02-04 Hygia Bioscience Treatment of dermatological conditions
WO2021141955A1 (en) * 2020-01-06 2021-07-15 Juvn3 Holdings, Llc Compositions and methods for increasing cellular vitality and longevity and decreasing molecular ageing
WO2023141574A1 (en) * 2022-01-21 2023-07-27 Beta Biofuel Solutions, Llc Topical therapeutic
CN114940950B (en) * 2022-03-28 2023-07-07 北京科技大学 Method for recycling clostridium butyricum fermentation waste liquid
CN115044532B (en) * 2022-06-23 2023-05-26 中国科学院海洋研究所 Construction and identification method of rapana venosa embryo cell line
CN115531594B (en) * 2022-10-19 2023-07-04 南通大学 Wound healing dressing for diabetes and preparation method thereof

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096704A1 (en) * 1970-06-17 1972-02-25 Millet Ingrid Cosmetic product - contg a substance obtained from fish eggs
FR2500305A1 (en) * 1981-02-24 1982-08-27 Mancori Alvaro Sperm extract for therapeutic and cosmetic cell revitalisation - by centrifuging to open spermatozoa cells and recovery of supernatant liq.
WO1989007425A2 (en) * 1988-02-17 1989-08-24 Genethics Limited Clinical developments using amniotic cells
RU2032398C1 (en) * 1993-06-10 1995-04-10 Научно-производственное предприятие "Фармэк" Cosmetic cream
JPH08169837A (en) * 1994-12-18 1996-07-02 Eiko Shimizu Therapeutic preparation to be applied to epidermis and containing egg oil as active component
RU2110984C1 (en) * 1996-01-03 1998-05-20 Товарищество с ограниченной ответственностью "Биокосметическая фабрика" Cosmetic marecream for skin care
US5985333A (en) * 1993-02-10 1999-11-16 Pharmec Pharmaceutical formulation containing a DNA-sodium salt for burn and wound treatment
DE19917532A1 (en) * 1999-04-19 2000-10-26 Christian Toloczyki Carrier-bound keratinocyte stem or precursor cells, useful for cosmetic or therapeutic regeneration of the epidermis
US6177550B1 (en) * 1996-03-15 2001-01-23 Ipr Institute For Pharmaceutical Research Ag Process for extraction of a growth factor complex
DE10001740A1 (en) * 2000-01-17 2001-07-26 Backhaus Jeannette Aqueous cosmetic cream or lotion comprises salmon or trout fish eggs at the breeding stage as the active agent
WO2001089540A1 (en) * 2000-05-23 2001-11-29 N.V. Nutricia Use of egg white and egg white fractions for tissue regeneration
WO2002018441A2 (en) * 2000-09-01 2002-03-07 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed fibrin-based matrices and tissues
CN1343496A (en) * 2001-06-15 2002-04-10 沈阳药科大学 Forest frog's egg fat injection and its preparing process
US20020048563A1 (en) * 2000-09-01 2002-04-25 Baetge E. Edward Methods and compositions for tissue regeneration
FR2827171A1 (en) * 2001-07-10 2003-01-17 Soc Extraction Principes Actif Use of an enzymatic hydrolysate of salmon eggs for preventing or treating the effects of aging caused by physiology or sunlight
KR20030075297A (en) * 2002-03-18 2003-09-26 권구상 Emulsion composition of nanosome containing caviar extract and cosmetic composition containing the same
FR2843123A1 (en) * 2002-07-31 2004-02-06 Saint Laurent Parfums Adult, multipotent human stem cells, useful for transplantation for e.g. tissue reconstruction or cosmetic purposes, are isolated from adipose tissue and do not induce rejection
RU2232587C1 (en) * 2003-03-07 2004-07-20 Зао "Мирра-М" Cosmetic preparation based upon aqua-homogenate of sturgeon caviar or based upon aqua-homogenate of salmon caviar or based upon complex of sturgeon and salmon caviar homogenates (variants)
WO2004084828A2 (en) * 2003-03-21 2004-10-07 Materials Evolution And Development Usa, Inc. Keratinocyte-fibrocyte concomitant grafting for wound healing
US20050214257A1 (en) * 2003-12-23 2005-09-29 Northwestern University Compositions and methods for controlling stem cell and tumor cell differentiation, growth, and formation
WO2005099758A2 (en) * 2004-04-17 2005-10-27 The Board Of Trustees The Leland Standford Junior University Injectable bioartificial tissue matrix
EP1600501A1 (en) * 2004-05-26 2005-11-30 L'oreal Use of lif for tissue and cellular engineering
US20050271751A1 (en) * 2004-06-04 2005-12-08 Laboratoire De Dermocosmetique Active principle which is capable of inducing the conversion of inactive TGFb-latent into active TGFb
EP1629830A1 (en) * 2003-05-30 2006-03-01 Nikolai Alexeevich Kostelev Cosmetic preparation

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1327825A (en) * 1962-04-10 1963-05-24 Inst Delcourt Process for preparing beauty products, creams, cosmetics or the like and products obtained by said process
US3852489A (en) * 1973-04-06 1974-12-03 New England Fish Co Food products and the preservation and enhancing of the appearance thereof
CA1341469C (en) 1988-08-04 2004-12-28 Robert Lindsay Williams In vitro propagation of embryonic stem cells
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5226914A (en) 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5197985A (en) * 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
JPH07500001A (en) 1991-06-18 1995-01-05 キャプラン，アーノルド，アイ． Monoclonal antibody specific for bone marrow-derived mesenchymal cells
US5750376A (en) * 1991-07-08 1998-05-12 Neurospheres Holdings Ltd. In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
US5340740A (en) * 1992-05-15 1994-08-23 North Carolina State University Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
US5928947A (en) 1992-07-27 1999-07-27 California Institute Of Technology Mammalian multipotent neural stem cells
US5849553A (en) 1992-07-27 1998-12-15 California Institute Of Technology Mammalian multipotent neural stem cells
US5654183A (en) 1992-07-27 1997-08-05 California Institute Of Technology Genetically engineered mammalian neural crest stem cells
US5589376A (en) 1992-07-27 1996-12-31 California Institute Of Technology Mammalian neural crest stem cells
US5453357A (en) * 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5480772A (en) * 1993-02-03 1996-01-02 Brandeis University In vitro activation of a nucleus
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
US5591625A (en) * 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
NZ279995A (en) 1994-01-21 1998-04-27 Powderject Vaccines Inc Gas driven gene delivery instrument with a conical exit nozzle and a cartridge with an arcuate, linear passage
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5968829A (en) * 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
JP2000086425A (en) * 1998-09-14 2000-03-28 Bizen Kasei Kk Skin-whitening agent and skin whitening composition containing the same
US7144729B2 (en) * 2000-09-01 2006-12-05 Dfb Pharmaceuticals, Inc. Methods and compositions for tissue regeneration
US20020076816A1 (en) * 2000-12-04 2002-06-20 Jianwu Dai Stem cells and signals developed for use in tissue and organ repair and replacement
EP1356035B1 (en) * 2000-12-22 2011-03-16 Kyowa Hakko Kirin Co., Ltd. Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells
US7491534B2 (en) * 2000-12-22 2009-02-17 Kirin Holdings Kabushiki Kaisha Methods for altering cell fate to generate T-cells specific for an antigen of interest
US20020142397A1 (en) * 2000-12-22 2002-10-03 Philippe Collas Methods for altering cell fate
KR20020093251A (en) 2001-06-07 2002-12-16 로제화장품 주식회사 A cosmetic composition containing mixing extract of shipjangsaeng-related natural substance(Pinus sylvestris, Ganoderma lucidum Karst., Arbutin, Cervus elaphus L., Amyda sinensis, Germanum, Apis mellifera L., Panax ginseng C. A. Meyer, salmon egg, Citrus Medica Limonum)
WO2004013275A2 (en) * 2002-07-31 2004-02-12 Yves Saint-Laurent Parfums Stem cells derived from adipous tissue and differentiated cells derived from said cells
JP2004323401A (en) * 2003-04-23 2004-11-18 Mikimoto Pharmaceut Co Ltd Skin care preparation for external use
US6946403B2 (en) * 2003-10-28 2005-09-20 Axcelis Technologies, Inc. Method of making a MEMS electrostatic chuck
US20050260181A1 (en) * 2004-03-05 2005-11-24 Immunopath Profile, Inc. Compositions and methods for tissue repair
AU2007285483B2 (en) 2006-05-11 2011-12-22 Regenics As Administration of cells and cellular extracts for rejuvenation
EP1938866B1 (en) 2006-12-22 2011-09-21 Nippon Barrier Free Co. Ltd. Cosmetic product comprising a component extracted from a Salmonidae fish ovarian membrane
EP2296676B1 (en) 2008-05-09 2016-11-02 Regenics AS Cellular extracts
AU2011249478B2 (en) 2010-05-06 2014-12-04 Regenics As Use of cellular extracts for skin rejuvenation
PE20150269A1 (en) 2012-01-23 2015-02-19 Restorsea Llc COSMETIC COMPOSITION CONTAINING AN EGG Hatching PROTEIN

Patent Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096704A1 (en) * 1970-06-17 1972-02-25 Millet Ingrid Cosmetic product - contg a substance obtained from fish eggs
FR2500305A1 (en) * 1981-02-24 1982-08-27 Mancori Alvaro Sperm extract for therapeutic and cosmetic cell revitalisation - by centrifuging to open spermatozoa cells and recovery of supernatant liq.
WO1989007425A2 (en) * 1988-02-17 1989-08-24 Genethics Limited Clinical developments using amniotic cells
US5985333A (en) * 1993-02-10 1999-11-16 Pharmec Pharmaceutical formulation containing a DNA-sodium salt for burn and wound treatment
RU2032398C1 (en) * 1993-06-10 1995-04-10 Научно-производственное предприятие "Фармэк" Cosmetic cream
JPH08169837A (en) * 1994-12-18 1996-07-02 Eiko Shimizu Therapeutic preparation to be applied to epidermis and containing egg oil as active component
RU2110984C1 (en) * 1996-01-03 1998-05-20 Товарищество с ограниченной ответственностью "Биокосметическая фабрика" Cosmetic marecream for skin care
US6177550B1 (en) * 1996-03-15 2001-01-23 Ipr Institute For Pharmaceutical Research Ag Process for extraction of a growth factor complex
DE19917532A1 (en) * 1999-04-19 2000-10-26 Christian Toloczyki Carrier-bound keratinocyte stem or precursor cells, useful for cosmetic or therapeutic regeneration of the epidermis
DE10001740A1 (en) * 2000-01-17 2001-07-26 Backhaus Jeannette Aqueous cosmetic cream or lotion comprises salmon or trout fish eggs at the breeding stage as the active agent
WO2001089540A1 (en) * 2000-05-23 2001-11-29 N.V. Nutricia Use of egg white and egg white fractions for tissue regeneration
WO2002018441A2 (en) * 2000-09-01 2002-03-07 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed fibrin-based matrices and tissues
US20020048563A1 (en) * 2000-09-01 2002-04-25 Baetge E. Edward Methods and compositions for tissue regeneration
CN1343496A (en) * 2001-06-15 2002-04-10 沈阳药科大学 Forest frog's egg fat injection and its preparing process
FR2827171A1 (en) * 2001-07-10 2003-01-17 Soc Extraction Principes Actif Use of an enzymatic hydrolysate of salmon eggs for preventing or treating the effects of aging caused by physiology or sunlight
KR20030075297A (en) * 2002-03-18 2003-09-26 권구상 Emulsion composition of nanosome containing caviar extract and cosmetic composition containing the same
FR2843123A1 (en) * 2002-07-31 2004-02-06 Saint Laurent Parfums Adult, multipotent human stem cells, useful for transplantation for e.g. tissue reconstruction or cosmetic purposes, are isolated from adipose tissue and do not induce rejection
RU2232587C1 (en) * 2003-03-07 2004-07-20 Зао "Мирра-М" Cosmetic preparation based upon aqua-homogenate of sturgeon caviar or based upon aqua-homogenate of salmon caviar or based upon complex of sturgeon and salmon caviar homogenates (variants)
WO2004084828A2 (en) * 2003-03-21 2004-10-07 Materials Evolution And Development Usa, Inc. Keratinocyte-fibrocyte concomitant grafting for wound healing
EP1629830A1 (en) * 2003-05-30 2006-03-01 Nikolai Alexeevich Kostelev Cosmetic preparation
US20050214257A1 (en) * 2003-12-23 2005-09-29 Northwestern University Compositions and methods for controlling stem cell and tumor cell differentiation, growth, and formation
WO2005099758A2 (en) * 2004-04-17 2005-10-27 The Board Of Trustees The Leland Standford Junior University Injectable bioartificial tissue matrix
EP1600501A1 (en) * 2004-05-26 2005-11-30 L'oreal Use of lif for tissue and cellular engineering
US20050271751A1 (en) * 2004-06-04 2005-12-08 Laboratoire De Dermocosmetique Active principle which is capable of inducing the conversion of inactive TGFb-latent into active TGFb

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 199550, Derwent World Patents Index; AN 1995-391554, XP002541282 *
DATABASE WPI Week 199636, Derwent World Patents Index; AN 1996-358474, XP002541286 *
DATABASE WPI Week 199850, Derwent World Patents Index; AN 1998-592723, XP002541281, "Anti-ageing face cream compositon" *
DATABASE WPI Week 200254, Derwent World Patents Index; AN 2002-501261, XP002541285 *
DATABASE WPI Week 200410, Derwent World Patents Index; AN 2004-095315, XP002541284 *
DATABASE WPI Week 200456, Derwent World Patents Index; AN 2004-578293, XP002541283 *
T.E. GOTTSCHALCK, G.N. MCEWEN, JR.: "International Cosmetic Ingredient Dictionary and Handbook", 2004, THE COSMETIC, TOILETRY AND FRAGRANCE ASSOCIATION, WASHINGTON, D.C., XP002541280 *
WERNER BALTES: "Lebensmittelchemie", 1995, SPRINGER VERLAG, BERLIN, XP002541279 *

Also Published As

Publication number Publication date
CA2651856A1 (en) 2008-02-21
RU2008148849A (en) 2010-06-20
RU2453301C1 (en) 2012-06-20
AU2007285483B2 (en) 2011-12-22
JP2015063528A (en) 2015-04-09
EP2101724B1 (en) 2020-12-02
EP2656832A3 (en) 2014-08-06
RU2421208C2 (en) 2011-06-20
EP2101724A2 (en) 2009-09-23
US20150290252A1 (en) 2015-10-15
US8460713B2 (en) 2013-06-11
WO2008020329A2 (en) 2008-02-21
US8075920B2 (en) 2011-12-13
JP5641734B2 (en) 2014-12-17
DK2656832T3 (en) 2019-04-08
EP2656832A2 (en) 2013-10-30
US20130261063A1 (en) 2013-10-03
JP6177750B2 (en) 2017-08-09
EP2656832B1 (en) 2018-12-19
JP2009538826A (en) 2009-11-12
AU2007285483A1 (en) 2008-02-21
US11033587B2 (en) 2021-06-15
US20090175927A1 (en) 2009-07-09
US20120027705A1 (en) 2012-02-02
CA2651856C (en) 2015-09-29
US9066883B2 (en) 2015-06-30

Similar Documents

Publication Publication Date Title
WO2008020329A3 (en) Administration of cells and cellular extracts for rejuvenation
WO2009136291A3 (en) Cellular extracts
US8071106B2 (en) Topical formulation containing latex of fraction thereof, and cosmetic treatment method
KR101678621B1 (en) Composition comprising spicules for skin care
EP1768500B1 (en) Compositions suitable for treating cutaneous signs of aging
JP2009538826A5 (en)
WO2005079822A3 (en) Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds
WO2011138687A3 (en) Use of cellular extracts for skin rejuvenation
CN109152724B (en) Synergistic extract of palmaria palmiformis and jasmine, composition containing synergistic extract and application of synergistic extract
WO2005000245A3 (en) Compositions and methods for increasing telomerase activity
ES2623480T3 (en) One or more extracts of Vigna marina, Cocos nucifera L. or Terminalia catappa L. for the treatment of wounds, skin disorders and hair loss
US20160008269A1 (en) Cosmetic composition containing a brown alga extract, a yeast extract and ascorbic acid
KR102606356B1 (en) Cosmetic composition for regenerating skin and improving skin wrinkle
Chakraborty et al. Human aqueous placental extract as a wound healer
KR102202391B1 (en) Synergistic combination of alanine-glutamine, hyaluronic acid and an oat extract and the use thereof in a composition intended for healing wounds and repairing skin lesions
Soni et al. Effect of ethanolic extract of cinnamomum tamala leaves on wound healing in stz induced diabetes in rats
KR101798632B1 (en) Cosmetic composition containing stellera chamaejasme extract or fraction thereof and use thereof
WO2014140930A3 (en) Compostions and methods for enhancing the therapeutic potential of stem cells
JP2016517861A (en) Method for obtaining a mixture of neutral oligosaccharides extracted from flax seeds
WO2009036220A3 (en) Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes
US10071122B2 (en) Heat-extracted omentum extracts, compositions, methods of preparing and uses thereof
TW201125592A (en) Terminalia catappa leaf extracts for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen and uses of the same
KR101623189B1 (en) Composition for tissue regeneration containing proteins derived from mesenchymal stem cell
Surya et al. Papaya Latex for Healing the Second Degree of Burn Wound in Male Mice
EP3681994B1 (en) Catalyst for the regeneration of tissues and related method for making it

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2009508547

Country of ref document: JP

Ref document number: 2651856

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007285483

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2007825530

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2007285483

Country of ref document: AU

Date of ref document: 20070511

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2008148849

Country of ref document: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07825530

Country of ref document: EP

Kind code of ref document: A2